title: Growth hormone (GH) suppression of catecholamine turnover in the chicken hypothalamus: implications for GH autoregulation.
abstract: GH administered centrally or peripherally inhibits basal or secretagogue-induced GH secretion in domestic fowl. Since the release of pituitary GH is neurally regulated by the hypothalamus, GH autoregulation may be mediated by changes in the content or metabolism of hypothalamic monoamines. When chicken GH (500 micrograms/kg body weight) was injected i.v. into laying hens, tissue catecholamine (adrenaline, noradrenaline and dopamine) concentrations in the preoptic area (POA) and medial basal hypothalamus (MBH) were depleted for 2-24 h, as were concentrations of dihydroxyphenylacetic acid, a dopamine metabolite. The serotonin (5-HT) content of the POA and MBH was unaffected by i.v. GH administration, although a reduction in MBH 5-hydroxyindoleacetic acid suggested a tissue-specific inhibition of 5-HT turnover. Qualitatively similar results were observed in laying hens 24 h after the intracerebroventricular injection of chicken GH (10 micrograms/bird). These results therefore demonstrate aminergic actions of GH within the chicken hypothalamus which may mediate GH autoregulation. However, as amine metabolism is not only suppressed when endogenous GH secretion is reduced, but also at times when normal GH secretion is restored, these aminergic effects may also reflect other actions of GH on central function.
authors.affiliation: Department of Biology, Lancashire Polytechnic, Preston, U.K.
authors.forename: R W
authors.initials: RW
authors.lastname: Lea
authors.forename: S
authors.initials: S
authors.lastname: Harvey
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D002645:Chickens / Q000502:physiology*; D004298:Dopamine / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D005260:Female; D013006:Growth Hormone / Q000378:metabolism* / Q000494:pharmacology; D006706:Homeostasis; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D007275:Injections, Intravenous; D007276:Injections, Intraventricular; D009638:Norepinephrine / Q000378:metabolism
chemical_list: D002395:Catecholamines; D015102:3,4-Dihydroxyphenylacetic Acid; D013006:Growth Hormone; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine